The NICHD conducts and supports a variety of clinical research related to FXTAS. Select a link below to learn more about these projects.
Featured NICHD Clinical Trials
- Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
In this study, researchers will examine the effects of memantine over a 2-year period to see if it is effective in treating the symptoms of FXTAS. Memantine is used to treat Alzheimer's disease; it can help people with Alzheimer's disease think more clearly and perform daily activities more easily.
NICHD Clinical Trials
ClinicalTrials.gov Search Results
Information on current NIH-sponsored clinical trials on FXTAS is available by following the link below or by calling 800-411-1222.
BACK TO TOP